Skip to main content
. 2013 Apr 11;108(10):2164–2171. doi: 10.1038/bjc.2013.143

Table 3. Detection of rare BRAF mutations with different methods.

Patient ID Pyrosequencing/Sanger sequencing COBAS Immunohistochemistry BRAF V600E Localisation/organ
1 V600K × Brain
 
V600K
ND
ND
uk
2 V600EK601del × ND Primary tumour
  V600EK601del ND Stomach
 
V600EK601del
ND

Pancreas
3 V600D × ND Lymph node
  V600D ND × Lung
 
V600D
×
ND
uk
4
V600G
×
ND
Liver
5 V600K ND uk
 
V600K

×
Lymph node
6
V600K

ND
uk
7 L597S × ND uk
  L597S ND ×  
 
L597S
ND
ND
Lymph node
8 V600E2 (GAA) Invalid Primary tumour
 
V600E2 (GAA)
×

Lymph node
9 V600DK601del × Skin
 
V600DK601del
ND
×
Skin
10 V600R ND × Skin
  V600R ND × Skin
  V600R ND × Skin
  V600R × × Skin
 
V600R
×
×
Skin
11
V600K

ND
Skin
12 V600K Invalid ND Skin
  V600K ND × Skin
  V600K ND Lung
  V600K ND × Skin
 
V600K
Invalid
ND
Skin
13 V600K ND Skin
 
V600K
ND

Skin
14 V600E2 (GAA) × ND Skin
  V600E2 (GAA) × ND Skin

Abbreviations: ND=not done; √=mutation detected; × =mutation not detected; Invalid=no result; uk=unknown.